Shares of Cipla gained nearly 2 per cent on Monday, following the United States Food and Drug Administration (USFDA) classifying its Goa facility as “Voluntary Action Indicated” (VAI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback